Dr. Ferrarone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E 70th St
New York, NY 10021Phone+1 212-746-9663Fax+1 212-746-3609
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2018- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2012 - 2015
New York Medical CollegeClass of 2012
Certifications & Licensure
NY State Medical License 2015 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 23 citationsGCN2 kinase activation by ATP-competitive kinase inhibitors.Colin P Tang, Owen Clark, John R Ferrarone, Carl Campos, Alshad S Lalani
Nature Chemical Biology. 2022-02-01 - 59 citationsHyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells.Arun M. Unni, Bryant T. Harbourne, Min Hee Oh, Sophia A Wild, John Ferrarone
Elife. 2018-11-26 - 54 citationsImpaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1Dennis Liang Fei, Tao Zhen, Benjamin H. Durham, John Ferrarone, Tuo Zhang
Proceedings of the National Academy of Sciences of the United States of America. 2018-10-30
Journal Articles
- Impaired Hematopoiesis and Leukemia Development in Mice with a Conditional Knock-in Allele of a Mutant Splicing Factor Gene U2af1John Ferrarone, MD, Proceedings of the National Academy of Sciences
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
